Simon Plyte

Vice President Immuno-Oncology
Nina E. Weisser
Dr Plyte is responsible for creating and maintaining an innovative Immune-Oncology portfolio of Bi-specific (Biclonic) antibodies for the treatment of Cancer. He is leading the research and development of drugs at the preclinical level from exploratory idea through to IND submission.


No data was found